More

Plasmid-Based Analgesic

Plasmid DNA (pDNA) comprises small circular DNA molecules employed in biotechnology as a platform for recombinant protein production in human cells.
Through genetic engineering, a DNA sequence encoding the target recombinant protein is inserted into the plasmid vector. Following pDNA injection, the encoded protein undergoes transient expression in human cells, enabling its intended biological functions.

Application No. 3219798: European Patent

Application No. 2597789: Analgesic Agent Based on Plasmid DNA Encoding HNP-1, HNP-2, or HNP-3 (Variants)

Eurasian No. 20170092364 (filed 26.11.2017)

China No. 2015872724 (filed 07.07.2017)

Hong Kong No. 18103246.6 (filed 07.07.2017)

Korea No. 20177015883 (filed 10.11.2015)

Eurasian No. 201790929 (filed 10.11.2015)

Japan No. 2017535288 (filed 09.05.2017)

Brazil No. 1120170096072 (filed 08.05.2017)

U.S. No. 2018057837 (filed 10.11.2015)

India No. 201717019831 (filed 06.06.2017)

Israel No. 252730 (filed 06.06.2017)

2017 — International Inventive Design Competition, Hong Kong

2017 — Archimedes Salon, Moscow. Diploma. Gold Medal

2017 — Salon "New Time", Sevastopol. Diploma. Gold Medal

2019 — Salon international des inventions, Geneva

2019 — Salon international des inventions, Geneva

2018 — World Genius Convention, Japan

Leave your request, and we will contact you.

Phone:

Email: